For the third time, Lankenau Medical Center was
named a Top Performer on Key Quality Measures® by The Joint Commission,
the leading accreditor of health care organizations in America. Lankenau
was recognized for their exemplary performance in using evidence-based
clinical processes that are shown to improve care for certain
“This recognition by The Joint Commission serves as a validation that
the best health care can be found right in the community,” said Phillip
Robinson, president, Lankenau Medical Center, part of Main Line Health.
“We once again owe this achievement to the outstanding accomplishments
of our physicians, nurses and health care staff who provide the highest
level of care to our patients every day.”
Lankenau is one of 1,224 hospitals in the U.S. earning the distinction
of Top Performer on Key Quality Measures for attaining and sustaining
excellence in accountability measure performance. Two other Main Line
Health hospitals, Paoli and Riddle
hospitals, also made the list.
Lankenau was recognized for its achievement on the following measure
sets: heart attack, heart failure, pneumonia and surgical care. The
ratings are based on an aggregation of accountability measure data
reported to The Joint Commission during the 2013 calendar year.
To be a 2013 Top Performer, hospitals had to meet three performance
criteria based on 2013 accountability measure data, including:
Achieving cumulative performance of 95 percent or above
across all reported accountability measures;
Achieving performance of 95 percent or above on each and
every reported accountability measure where there were
at least 30 denominator cases; and
Having at least one core measure set that had a
composite rate of 95 percent or above, and (within that
measure set) all applicable individual accountability
measures had a performance rate of 95 percent or above.
“Delivering the right treatment in the right way at the right time is a
cornerstone of high-quality health care. I commend the efforts of
Lankenau Medical Center for their excellent performance on the use of
evidence-based interventions,” said Mark R. Chassin, MD, FACP, MPP, MPH,
president and CEO, The Joint Commission.
For more information about the Top Performer program, visit
The Joint Commission website.